John F. Paolini - 13 Nov 2026 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

SEC form
4
Accepted by SEC
17 Nov 2026, 16:36:02 UTC
Prior SEC filing
03 Nov 2026
Source filing
View source filing
Filing notes and source

Key filing fact

John F. Paolini filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 17 Nov 2026.

Key facts

  • This page summarizes John F. Paolini's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
  • 10 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 17 Nov 2026, 16:36.

Change

  • Previous filing in this sequence was filed on 03 Nov 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001741533 Primary reporting owner

Paolini John F.

Relationship
CHIEF MEDICAL OFFICER

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+29,670
Change %
+42%
Price
$10.36*
Shares after
99,592
Date
13 Nov 2026
Ownership
Direct
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+4,994
Change %
+5%
Price
$11.10*
Shares after
104,586
Date
13 Nov 2026
Ownership
Direct
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+3,723
Change %
+3.6%
Price
$11.97*
Shares after
108,309
Date
13 Nov 2026
Ownership
Direct
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+3,144
Change %
+2.9%
Price
$12.97*
Shares after
111,453
Date
13 Nov 2026
Ownership
Direct
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+2,595
Change %
+2.3%
Price
$15.52*
Shares after
114,048
Date
13 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-29,670
Change %
-100%
Price
$0.000000*
Shares after
0
Date
13 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
29,670
Exercise price
$10.36
Footnotes
F1
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-4,994
Change %
-8.3%
Price
$0.000000*
Shares after
54,936
Date
13 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
4,994
Exercise price
$11.10
Footnotes
F1
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-3,723
Change %
-6.2%
Price
$0.000000*
Shares after
56,207
Date
13 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
3,723
Exercise price
$11.97
Footnotes
F1
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-3,144
Change %
-7.6%
Price
$0.000000*
Shares after
38,256
Date
13 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
3,144
Exercise price
$12.97
Footnotes
F1
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-2,595
Change %
-5.2%
Price
$0.000000*
Shares after
47,405
Date
13 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
2,595
Exercise price
$15.52
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .